Role of corticotropin-releasing factor (CRF) receptors in the anorexic syndrome induced by CRF

Journal of Pharmacology and Experimental Therapeutics

Volumn 293, Issue 3, 2000, Pages 799-806

  Pelleymounter, Mary Ann ^a,b   Joppa, Margaret ^a   Carmouche, Michelle ^a   Cullen, Mary Jane ^a   Brown, Brock ^a   Murphy, Brian ^a   Grigoriadis, Dimitri E ^a   Ling, Nick ^a   Foster, Alan C ^a  

^a Departments of Pharmacology   (United States)

^b NEUROCRINE BIOSCIENCES INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 CHLORO 4 [N (CYCLOPROPYLMETHYL) N PROPYLAMINO] 2 METHYL 6 (2,4,6 TRICHLOROANILINO)PYRIMIDINE; ANTISAUVAGINE 30; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR; NBI 27941; UNCLASSIFIED DRUG; UROTENSIN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANOREXIA; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; FEMALE; FOOD INTAKE; FREEZING; LOCOMOTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REFLEX; STRESS;

ANIMALS; ANOREXIA; BEHAVIOR, ANIMAL; CORTICOTROPIN-RELEASING HORMONE; DOSE-RESPONSE RELATIONSHIP, DRUG; EATING; FEMALE; MICE; MOTOR ACTIVITY; PEPTIDE FRAGMENTS; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE;

EID: 0034126717     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Arase K, York DA, Shimizu H, Shargill N and Bray GA (1988) Effects of cortictropin-releasing factor on food intake and brown adipose tissue thermogenesis in rats. Am J Physiol 255:E255-E259.
2. Behan DP, Grigoriadis DE, Lovenberg T, Chalmers D, Heinrichs S, Liaw C and DeSouza E (1996) Neurobiology of corticotropin releasing factor (CRF) receptors and CRF-binding protein: Implications for the treatment of CNS disorders. Mol Psychiatry 1:265-277.
3. Britton DR, Koob GF and Rivier J (1982) Intraventricular corticotropin releasing factor enhances behavioral effects of novelty. Life Sci 31:363-367.
4. Britton KL, Lee G, Dana R, Risch SC and Koob GF (1986a) Activating and 'anxiogenic' effects of corticotropin releasing factor are not inhibited by blockade of the pituitary-adrenal system with dexamethasone. Life Sci 39:1282-1286.
5. Britton KL, Lee G, Vale W, Rivier J and Koob G (1986b) Corticotropin releasing factor (CRF) receptor antagonist blocks activating and 'anxiogenic' actions of CRF in the rat. Brain Res 369:303-306.
6. 1 receptor mRNA expression. J Neurosci 15:6340-6350.
7. Chen R, Lewis KA, Perrin MH and Vale WW (1993) Expression cloning of a human corticotropin-releasing factor receptor. Prof Natl Acad Sci USA 90:8967-8971.
8. Conti LH, Costello DG, Martin LA, White MF and Abreu ME (1994) Mouse strain differences in the behavioral effects of corticotropin-releasing factor (CRF) and the CRF antagonist alpha helical CRF (9-41) Pharmacol Biochem Behav 48:497-503.
9. Dunn AJ and Berridge CW (1987) Corticotropin releasing factor administration elicits a stress-like activation of cerebral catecholaminergic systems. Pharmacol Biochem Behav 27:685-691.
10. Emoto H, Koga C, Ishii H, Yokoo H, Yoshida M and Tanaka M (1993b) A CRF antagonist attenuates stress-induced increases in NA turnover in extended brain regions in rats. Brain Res 627:171-176.
11. Emoto H, Tanaka M, Koga C, Yokoo H, Tsuda A and Yoshida M (1993a) Corticotropin-releasing factor activates the noradrenergic neuron system in the rat brain. Pharmacol Biochem Behav 45:419-422.
12. Gosnell BA, Morley JE and Levine AS (1983) A comparison of the effects of corticotropin releasing factor and sauvagine on food intake. Pharmacol Biochem Behav 19:771-775.
13. 2α receptors. Mol Pharmacol 50:679-686.
14. Heinrichs SC, Lapsansky J, Lovenberg TW, DeSouza EB and Chalmers DT (1997) Corticotropin releasing factor CRF1, but not CRF2, receptors mediate anxiogenic-like behavior. Regul Pept 71:15-21.
15. Herzog DB, Nussbaum KM and Marmor AK (1996) Comorbidity and outcome in eating disorders, in The Psychiatric Clinics of North America (Yager J ed) vol 19, pp 843-859, WB Saunders Company, Philadelphia.
16. 2gamma receptor. Mol Endocrinol 12:1077-1085.
17. Krahn DD, Gosnell BA and Majchrzak MJ (1990) The anorectic effects of CRH and restraint stress decrease with repeated exposures. Biol Psychiatry 27:1094-1102.
18. Lavicky J and Dunn AJ (1993) Corticotropin-releasing factor stimulates catecholamine release in hypothalamus and prefrontal cortex in freely moving rats as assessed by microdialysis. J Neurochem 60:602-612.
19. LeFeuvre RA, Rothwell NJ and Stock MJ (1987) Activation of brown fat thermogenesis in response to central injection of corticotropin releasing hormone in the rat. Neuropharmacology 26:1217-1221.
20. Liebsch G, Landgraf R, Engelmann M, Lorscher P and Hoelsboer F (1999) Differential behavioral effects of chronic infusion of CRH 1 and CRH 2 receptor antisense oligonucleotides into the rat brain. J Psychiatr Res 33:153-163.
21. Lovenberg TW, Liaw CW, Grigoriadis DE, Clevenger W, Chalmers DT, DeSouza EB and Oltersdorf T (1995) Cloning and characterization of a functionally distinct corticotropin releasing factor receptor subtype from rat brain. Proc Natl Acad Sci USA 92:836-840.
22. Mansbach RS, Brooks EN and Chen YL (1997) Antidepressant-like effects of CP-154,526, a selective CRF1 receptor antagonist. Eur J Pharmacol 323:21-26.
23. Matsuzaki I, Takamatsu Y and Moroji T (1989) The effects of intracerebroventricularly injected corticotropin releasing factor (CRF) on the central nervous system: Behavioral and biochemical studies. Neuropeptides 13:147-155.
24. Moreau J-L, Kilpatrick G and Jenck F (1997) Urocortin, a novel neuropeptide with anxiogenic-like properties. Neuroreport 8:1697-1701.
25. Morley JE and Levine AS (1982) Corticotropin releasing factor, grooming and ingestive behaviors. Life Sci 31:1459-1464.
26. Okuyama S, Chaki S, Kawashima N, Suzuki Y, Ogawa S-I, Nakazato A, Kumagai T, Okubo T and Tomisawa K (1999) Receptor binding, behavioral and electrophysiological profiles of nonpeptide corticotropin-releasing factor subtype I receptor antagonists CRA1000 and CRA1001. J Pharmacol Exp Ther 289:926-935.
27. Perrin MH, Donaldson CH, Chen R, Lewis KA and Vale WW (1993) Cloning and functional expression of a rat brain corticotropin releasing factor (CRF) receptor. Endocrinology 133:3058-3061.
28. Pollice C, Kaye WH, Greeno CG and Weltzin TE (1997) Relationship of depression, anxiety and obsessionality to state of illness in anorexia nervosa. Int J Eat Disord 21:367-376.
29. Radulovic J, Ruhman A, Leipold R and Spiess J (1999) Modulation of learning and anxiety by corticotropin releasing factor (CRF) and stress: Differential roles of CRF receptors 1 and 2. J Neurosci 19:5016-5025.
30. Ruhman A, Bonk I, Lin CR, Rosenfeld MG and Spiess J (1998) Structural requirements for peptidic antagonists of the corticotropin-releasing factor receptor (CRFR): Development of CRFR2B-selective antisauvagine-30. Proc Natl Acad Sci USA 95:15264-15269.
31. Schulz DW, Mansbach RS, Sprous J, Braselton JP, Collins J, Corman M, Dunaiskis A, Faraci S, Schmidet AW, Seeger T, Seymour P, Tingley FD, Winston EN, Chen YL and Heym J (1996) CP-154,526: A potent and selective nonpeptide antagonist of corticotropin releasing factor receptors. Proc Natl Acad Sci USA 93:10477-10482.
32. Shimizu N, Nakane H, Hori T and Hayashi Y (1994) CRF receptor antagonist attenuates stress-induced noradrenaline release in the medial prefrontal cortex of rats. Brain Res 654:145-148.
33. Skutella T, Probst JC, Renner U, Holsboer F and Behl C (1998) Corticotropin releasing hormone receptor (Type 1) antisense targeting reduces anxiety. Neuroscience 85:795-805.
34. Smagin GN, Howell LA, Ryan DH, DeSouza DB and Harris HB (1998) The role of CRF2 receptors in corticotropin releasing factor and urocortin-induced anorexia. Neuroreport 9:1601-1606.
35. Smith GW, Aubry J-M, Dellu F, Contarino A, Bilezikjian LM, Gold LH, Chen R, Marchuk Y, Hauser C, Bentley CA, Sawchenko PE, Koob GF, Vale W and Lee K-F (1998) Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response and aberrant neuroendocrine development. Neuron 20:1093-1102.
36. Spina M, Merlo-Pich E, Chan RKW, Basso AM, Rivier J, Vale W and Koob GF (1996) Appetite-suppressing effects of urocortin, a CRF-related neuropeptide. Science (Wash DC) 273:1561-1564.
37. Sutton RE, Koob GF, LeMoal M, Rivier J and Vale W (1982) Corticotropin releasing factor produces behavioral activation in rats. Nature (Lond) 297:331-333.
38. Timpl P, Spanagel R, Sillaber I, Kresse A, Reul JMHM, Stalla GK, Blanquet V, Steckler T, Holsboer F and Wurst W (1998) Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1. Nat Genet 19:162-166.
39. Vaughan J, Donaldson C, Bittencourt J, Perrin MH, Lewis K, Sutton S, Chan R, Turnbull AV, Lovejoy D, Rivier C, Rivier J, Sawchenko PE and Vale W (1995) Urocortin, a mammalian neuropeptide related fish urotensin I and to corticotropin-releasing factor. Nature (Lond) 378:287-292.
40. Whitten JP, Xie YF, Erickson PE, Webb TR, DeSouza EB, Grigoriadis DE and McCarthy JR (1996) Rapid microscale synthesis, a new method for lead optimization using robotics and solution phase chemistry: Application to the synthesis and optimization of corticotropin releasing factor 1 receptor antagonists. J Med Chem 39:4354-4357.